ANIX

Anixa Biosciences Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

Anixa Biosciences Inc focuses on the development of treatments and vaccines for diseases such as cancer and viral infections.

$ 3.07
0.65 %

Anixa Biosciences Inc

$ 3.07
0.65 %
ANIX

Anixa Biosciences Inc focuses on the development of treatments and vaccines for diseases such as cancer and viral infections.

Price history of Anixa Biosciences Inc
Price history of Anixa Biosciences Inc

Performance & Momentum

6 Months 26.56 %
1 Year 12.45 %
3 Years 37.35 %
5 Years 34.68 %

Strategic Analysis

Anixa Biosciences Inc • 2026

Anixa Biosciences Inc develops innovative therapies in the biotechnology sector, particularly focused on oncology and viral diseases. Its emphasis on treatments and vaccines differentiates its approach by combining scientific innovation with targeted clinical potential.

Strengths
  • Positioning in segments with high unmet medical needs such as cancer
  • Expertise in innovative immunotherapies and vaccines
  • Valuation potential linked to clinical advancements and possible partnerships
Weaknesses
  • Fragile financial profile linked to operational results that are not yet profitable
  • History of stock performance marked by significant negative volatility
Momentum

The stock's momentum is weak, indicating persistent selling pressure and a challenging environment for valuation. This trend suggests that investors should adopt a cautious approach, closely monitoring clinical announcements or partnerships that could revive momentum.

Similar stocks to Anixa Biosciences Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone